Dublin, Nov. 28, 2023 (GLOBE NEWSWIRE) -- The "Sjogren's syndrome - Pipeline Insight, 2023" clinical trials has been added to ResearchAndMarkets.com's offering. This "Sjogren's syndrome - Pipeline ...
Novartis NVS announced that the FDA granted Breakthrough Therapy designation to its pipeline candidate, ianalumab for the treatment of adult patients with Sjogren's disease — a chronic, systemic ...
Here is the conclusion.Six new diseases are expected to be added to the "designated intractable diseases" list, which ...
Please provide your email address to receive an email when new articles are posted on . PHILADELPHIA — Results of a phase 2 proof-of-concept study showed that an oral Bruton’s tyrosine kinase ...
Investor's Business Daily on MSN
Amgen Boasts Success In Sjogren's; Shares Charge Ahead
Amgen stock bounded above its 50-day line Tuesday after publishing promising results for its experimental Sjogren's treatment.
Ainos (AIMD) has received Institutional Review Board approval from Shuang Ho Hospital, affiliated with Taipei Medical University, for its clinical trial of VELDONA in treating Sjogren’s syndrome.
Sjögren's syndrome (SS) is an autoimmune condition that causes dry eyes and mouth and sometimes other symptoms like joint pain or lung problems. Treatments like eye drops and medications can help ...
About two decades after the initial description of anti-NMDA receptor encephalitis, autoimmune encephalitis has expanded from being considered a neurological rarity to become one of the most rapidly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results